- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 4, 2026 | 9.36M sh |
| Shares Diluted | Q2 2026 · Apr 4, 2026 | 9.33M sh |
| Shares Diluted | Q2 2026 · Apr 4, 2026 | 9.31M sh |
| Shares Diluted restated | Q2 2026 · Mar 29, 2025 | 9.26M sh |
| Shares Diluted restated | Q2 2026 · Mar 29, 2025 | 9.26M sh |
| Capex | Q2 2026 · Apr 4, 2026 | $9.53M |
| Capex | Q2 2026 · Mar 29, 2025 | $11.21M |
| Operating Cash Flow | Q2 2026 · Apr 4, 2026 | −$136.55M |
| Operating Cash Flow | Q2 2026 · Mar 29, 2025 | −$154.31M |
| Long Term Debt | Q2 2026 · Apr 4, 2026 | $752.88M |
| Long Term Debt | Q2 2026 · Oct 4, 2025 | $752.06M |
| Long Term Debt | Q2 2026 · Mar 29, 2025 | $751.08M |
| Cash And Equivalents | Q2 2026 · Apr 4, 2026 | $16.92M |
| Cash And Equivalents | Q2 2026 · Oct 4, 2025 | $64.34M |
| Cash And Equivalents | Q2 2026 · Mar 29, 2025 | $17.25M |
| Stockholders Equity | Q2 2026 · Apr 4, 2026 | −$541.33M |
| Stockholders Equity | Q2 2026 · Jan 3, 2026 | −$489.85M |
| Stockholders Equity | Q2 2026 · Oct 4, 2025 | −$407.99M |
| Stockholders Equity | Q2 2026 · Mar 29, 2025 | −$269.46M |
| Stockholders Equity | Q2 2026 · Dec 28, 2024 | −$220.04M |
| Stockholders Equity | Q2 2026 · Sep 28, 2024 | −$177.15M |
| Current Liabilities | Q2 2026 · Apr 4, 2026 | $234.39M |
| Current Liabilities | Q2 2026 · Oct 4, 2025 | $209.06M |
| Current Liabilities | Q2 2026 · Mar 29, 2025 | $267.61M |
| Total Liabilities | Q2 2026 · Apr 4, 2026 | $1.26B |
| Total Liabilities | Q2 2026 · Oct 4, 2025 | $1.15B |
| Total Liabilities | Q2 2026 · Mar 29, 2025 | $1.31B |
| Current Assets | Q2 2026 · Apr 4, 2026 | $340.11M |
| Current Assets | Q2 2026 · Oct 4, 2025 | $328.79M |
| Current Assets | Q2 2026 · Mar 29, 2025 | $417.57M |
| Total Assets | Q2 2026 · Apr 4, 2026 | $715.46M |
| Total Assets | Q2 2026 · Oct 4, 2025 | $741.48M |
| Total Assets | Q2 2026 · Mar 29, 2025 | $1.04B |
| Eps Diluted | Q2 2026 · Apr 4, 2026 | −$5.63 |
| Eps Diluted | Q2 2026 · Apr 4, 2026 | −$14.55 |
| Eps Diluted restated | Q2 2026 · Mar 29, 2025 | −$5.54 |
| Eps Diluted restated | Q2 2026 · Mar 29, 2025 | −$10.36 |
| Eps Basic | Q2 2026 · Apr 4, 2026 | −$5.63 |
| Eps Basic | Q2 2026 · Apr 4, 2026 | −$14.55 |
| Eps Basic restated | Q2 2026 · Mar 29, 2025 | −$5.54 |
| Eps Basic restated | Q2 2026 · Mar 29, 2025 | −$10.36 |
| Sga Expense | Q2 2026 · Apr 4, 2026 | $92.21M |
| Sga Expense | Q2 2026 · Apr 4, 2026 | $177.88M |
| Sga Expense | Q2 2026 · Mar 29, 2025 | $92.33M |
| Sga Expense | Q2 2026 · Mar 29, 2025 | $179.74M |
| Net Income | Q2 2026 · Apr 4, 2026 | −$52.5M |
| Net Income | Q2 2026 · Apr 4, 2026 | −$135.47M |
| Net Income | Q2 2026 · Mar 29, 2025 | −$51.32M |
| Net Income | Q2 2026 · Mar 29, 2025 | −$95.88M |
| Operating Income | Q2 2026 · Apr 4, 2026 | −$37.69M |
| Operating Income | Q2 2026 · Apr 4, 2026 | −$106.43M |
| Operating Income | Q2 2026 · Mar 29, 2025 | −$48.38M |
| Operating Income | Q2 2026 · Mar 29, 2025 | −$88.08M |
| Gross Profit | Q2 2026 · Apr 4, 2026 | $53.35M |
| Gross Profit | Q2 2026 · Apr 4, 2026 | $80.42M |
| Gross Profit | Q2 2026 · Mar 29, 2025 | $43.95M |
| Gross Profit | Q2 2026 · Mar 29, 2025 | $91.66M |
| Cost Of Revenue | Q2 2026 · Apr 4, 2026 | $131.4M |
| Cost Of Revenue | Q2 2026 · Apr 4, 2026 | $251.46M |
| Cost Of Revenue | Q2 2026 · Mar 29, 2025 | $133.19M |
| Cost Of Revenue | Q2 2026 · Mar 29, 2025 | $260.7M |
| Revenue | Q2 2026 · Apr 4, 2026 | $184.74M |
| Revenue | Q2 2026 · Apr 4, 2026 | $331.87M |
| Revenue | Q2 2026 · Mar 29, 2025 | $177.13M |
| Revenue | Q2 2026 · Mar 29, 2025 | $352.36M |